NCT01260584View on ClinicalTrials.gov

The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Coronary Artery Disease
Interventions
DRUG

Prasugrel

One 10 mg film-coated, oral tablet daily x 10 days. In addition, aspirin 81 mg to 325 mg daily will be taken.

DRUG

Clopidogrel

One 75 mg film-coated, oral tablet daily x 10 days. In addition, aspirin 81 mg to 325 mg daily will be taken.

Trial Locations (3)

21215

Sanai Center for Thrombosis Research, Baltimore

45212

Medpace Clinical Pharmacology Unit, Cincinnati

45219

The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital, Cincinnati

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY